Carcinogens stimulate intrachromosomal homologous recombination at an endogenous locus in human diploid fibroblasts

Mutation Research - DNA Repair

Volumn 385, Issue 3, 1997, Pages 173-193

  Li, Jin ^a   Ayyadevara, Rajani ^b   Shmookler Reis, Robert J ^a,b,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c Med Biochem/Molec Biol U   (United States)

Author keywords

Cancer; Carcinogen; Carcinogenesis; Chromosomal rearrangement; Gene duplication; Genetic recombination; HGPRT; HPRT; Hypoxanthine (guanine) phosphoribosyltransferase; Lesch Nyhan syndrome

Indexed keywords

CARCINOGEN; DIETHYLSTILBESTROL; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; NICKEL CHLORIDE;

AMES TEST; ARTICLE; CARCINOGENESIS; DIPLOIDY; FIBROBLAST; GENE LOCUS; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; INTRON; LESCH NYHAN SYNDROME; MITOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SALMONELLA; SOUTHERN BLOTTING;

AMINOPTERIN; CARCINOGENS; CELLS, CULTURED; CHROMOSOME MAPPING; CLONE CELLS; CULTURE MEDIA; DNA; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LESCH-NYHAN SYNDROME; MULTIGENE FAMILY; MUTAGENICITY TESTS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECOMBINATION, GENETIC; ULTRAVIOLET RAYS;

SALMONELLA;

EID: 0031413921     PISSN: 09218777     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0921-8777(97)00054-2     Document Type: Article

References (92)

1. Leder P., Battey J., Lenoir G., Moulding C., Murphy W., Stewart T., Taub R. Translocations among antibody genes in human cancer. Science. 222:1983;765-771.
2. Solomon E., Borrow J., Goddard A.D. Chromosome aberrations and cancer. Science. 254:1991;1153-1160.
3. Yunis J.J. Multiple recurrent genomic rearrangements and fragile sites in human cancer. Somat. Cell Mol. Genet. 13:1987;397-403.
4. Cavenee W.K., Dryja T.P., Phillips R.A., Benedict W.F., Godbout R., Gallie B., Murphree A.L., Strong L.C., White R.L. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature. 305:1983;779-784.
5. James C.D., Carlbom E., Nordernskjold M., Collins V.P., Cavenee W.K. Mitotic recombination of chromosome 17 in astrocytomas. Proc. Natl. Acad. Sci. USA. 86:1989;2858-2862.
6. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutation Res. 113:1983;173-215.
7. Ames B.N., Gurney E.G., Miller J.A., Bartsch H. Carcinogens as frameshift mutagens: metabolites and derivatives of acetylaminofluorene and other aromatic amine carcinogens. Proc. Natl. Acad. Sci. USA. 69:1972;31128-31132.
8. Mason J.M., Langenbach R., Shelby M.D., Zeiger E., Tennant R.W. Ability of short-term tests to predict carcinogenesis in rodents. Annu. Rev. Pharmacol. Toxicol. 30:1990;149-168.
9. Quinto I., Tenenbaum L., Radman M. Genotoxic potency of nonfunctional alkylating agents in E. coli: comparison with carcinogenic potency in rodents. Mutation Res. 228:1990;177-185.
10. Tennant R.W., Margolin B.H., Shelby M.D., Zeiger E., Haseman J.K., Spalding J., Caspary W., Resnick M., Stasiewicz S., Anderson B.et al. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science. 236:1987;933-941.
11. Mendelsohn M.L., Moore D.H., Lohman P.H. International Commission for Protection against Environmental Mutagens and Carcinogens, a method for comparing and combining short-term genotoxicity test data: results and interpretation. Mutation Res. 266:1992;43-60.
12. Schiestl R.H., Gietz R.D., Mehta R.D., Hastings P.J. Carcinogens induce intrachromosomal recombination in yeast. Carcinogenesis. 10:1989;1445-1455.
13. Galli A., Schiestl R.H. Effects of Salmonella assay negative and positive carcinogens on intrachromosomal recombination in G1-arrested yeast cells. Mutation Res. 370:1996;209-221.
14. Ramel C., Cederberg H., Magnusson J., Vogel E., Natarajan A.T., Mullender L.H., Nivard J.M., Parry J.M., Leyson A., Comendador M.A., Sierra L.M., Ferreiro J.A., Consuegra S. Somatic recombination, gene amplification and cancer. Mutation Res. 353:1996;85-107.
15. Galli A., Schiestl R.H. Salmonella test positive and negative carcinogens show different effects on intrachromosomal recombination in G2 cell cycle arrested yeast cells. Carcinogenesis. 16:1995;659-663.
16. Schiestl R.H., Aubrecht J., Khogali F., Carls N. Carcinogens induce reversion of the mouse pink-eyed unstable mutation. Proc. Natl. Acad. Sci. USA. 94:1997;4576-4581.
17. Zhang L.H., Jenssen D. Studies on intrachromosomal recombination in SP5/V79 Chinese hamster cells upon exposure to different agents related to carcinogenesis. Carcinogenesis. 15:1994;2303-2310.
18. Yang T.P., Stout J.T., Konecki D.S., Patel P.I., Alford R.L., Caskey C.T. Spontaneous reversion of novel Lesch-Nyhan mutation by HPRT gene rearrangement. Somat. Cell Mol. Genet. 14:1988;293-303.
19. Cheng R.Z., Shammas M.A., Li J., Shmookler Reis R.J. Expression of SV40 large T antigen stimulates reversion of a chromosomal gene duplication in human cells. Exp. Cell Res. 234:1997;300-312.
20. Shammas M.A., Xia S.J., Shmookler Reis R.J. Induction of homologous recombination by wild-type and mutated SV40 T antigen covaries with the ability to induce host DNA synthesis. Genetics. 146:1997;1417-1428.
21. Monnat R.J. Jr., Chiaverotti T.A., Hackmann A.F., Maresh G.A. Molecular structure and genetic stability of human hypoxanthine phosphoribosyltransferase (HPRT) gene duplications. Genomics. 13:1992;788-796.
22. Aubrecht J., Rugo R., Schiestl R.H. Carcinogens induce intrachromosomal recombination in human cells. Carcinogenesis. 16:1995;2841-2846.
23. E.J. Moerman, S. Goldstein, Culture of human skin fibroblasts, in: W.L. Clarke et al. (Eds.), Methods in Diabetes Research, Vol. II: Clinical Methods, John Wiley and Sons, New York, 1986, pp. 283-312.
24. Finn G.K., Kurz B.W., Cheng R.Z., Shmookler Reis R.J. Homologous plasmid recombination is elevated in immortally transformed cells. Mol. Cell. Biol. 9:1989;4009-4017.
25. J. Sambrook, E.F. Fritsch, T. Maniatis, Isolation of high-molecular-weight DNA from mammalian cells, in: J. Sambrook et al. (Eds.), Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1989, pp. 9.14-9.19.
26. Jolly D.J., Esty A.C., Bernard H.U., Friedmann T. Isolation of a genomic clone partially encoding human hypoxanthine phosphoribosyltransferase. Proc. Natl. Acad. Sci. USA. 79:1982;5038-5041.
27. Feinberg A.P., Volgelstein B. Addendum: A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Analyt. Biochem. 137:1984;266-267.
28. IARC, Overall evaluation of carcinogenicity: an updating of IARC Monographs, IARC Monogr. Eval. Carcinog. Risks Hum., Vols. 1-42, Suppl. 7, International Agency for Research on Cancer, Lyon, 1987, pp. 1-440.
29. Fox J.G., Wishnok J.S., Murphy J.C., Tannenbaum S.R., Correa P. MNNG-induced gastric carcinoma in ferrets infected with Helicobacter mustelae. Carcinogenesis. 14:1993;1957-1961.
30. IARC, IARC monograph on the evaluation of carcinogenic risk to humans. Solar and ultraviolet radiation, IARC Monogr. Eval. Carcinog. Risks Hum., Vol. 55, International Agency for Research on Cancer, Lyon, 1992, pp. 1-316.
31. De Flora S., Serra D., Basso C., Zanacchi P. Mechanistic aspects of chromium carcinogenicity [Review]. Arch. Toxicol., Suppl. 13:1989;28-39.
32. Jensen J.C., Thilly W.G. Spontaneous and induced chromosomal aberrations and gene mutations in human lymphoblasts: mitomycin-C, methylnitrosourea, and ethylnitrosourea. Mutation Res. 160:1986;95-102.
33. Ishidate M. Jr., Harnois M.C., Sofuni T. A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell cultures. Mutation Res. 195:1988;151-213.
34. Herbst A.L., Ulfelder H., Poskanzer D.C. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 284:1971;878-881.
35. Nersessians A.K. Activity of human carcinogens in the Salmonella and rodent bone marrow cytogenetic tests. Mutation Res. 281:1992;239-243.
36. Costa M. Molecular mechanisms of nickel carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 31:1991;321-337.
37. Biggart N.W., Costa M. Assessment of the uptake and mutagenicity of nickel chloride in Salmonella tester strains. Mutation Res. 175:1986;209-215.
38. Jurícek M., Gichner T., Kocisová J., Yefremova G.I., Velemínsky J., Stanek J., Moravcová J., Jary J. Comparative mutagenicity of 3-azide-1, 2-propanediol and sodium azide in various pro- and eukaryote systems. Mutation Res. 179:1987;175-182.
39. Ulland B., Weisburger E.K., Weisburger J.H. Chronic toxicity and carcinogenicity of industrial chemicals and pesticides. Toxicol. Appl. Pharmacol. 25:1973;446. Abstract.
40. Haseman J.K., Clark A. Carcinogenicity results for 114 laboratory animal studies used to assess the predictivity of four in vitro genetic toxicity assays for rodent carcinogenicity. Environ. Mol. Mutagen. 18(Suppl. 16):1990;15-31.
41. Abdo K.M., Huff J.E., Haseman J.K., Alden C.J. No evidence of carcinogenicity of D-mannitol and propyl gallate in F344 rats or B6C3F1 mice. Food Chem. Toxicol. 24:1986;1091-1097.
42. Edwards A., Voss H., Rice P., Civitello A., Stegemann J., Schwager C., Zimmermann J., Erfle H., Caskey C.T., Ansorge W. Automated DNA sequencing of the human HPRT locus. Genomics. 6:1990;593-608.
43. Ayares D., Chekuri L., Song K.Y., Kucherlapati R. Sequence homology requirements for intermolecular recombination in mammalian cells. Proc. Natl. Acad. Sci. USA. 83:1986;5199-5203.
44. Nickoloff J.A., Reynolds R.J. Transcription stimulates homologous recombination in mammalian cells. Mol. Cell. Biol. 10:1990;4837-4845.
45. Thomas B.J., Rothstein R. Elevated recombination rates in transcriptionally active DNA. Cell. 56:1989;619-630.
46. Miller E.C. Some current perspectives on chemical carcinogenesis in humans and experimental animals: presidential address. Cancer Res. 38:1978;1479-1496.
47. Yang J.L., Hu M.C., Wu C.W. Novel mutational spectrum induced by N-methyl-N′-nitro-N-nitrosoguanidine in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase gene in diploid human fibroblasts. J. Mol. Biol. 221:1991;421-430.
48. Livneh Z., Cohen-Fix O., Skaliter R., Elizur T. Replication of damaged DNA and the molecular mechanism of ultraviolet light mutagenesis. Crit. Rev. Biochem. Mol. Biol. 28:1993;465-513.
49. Newbold R.F., Amos J., Connell J.R. The cytotoxic, mutagenic and clastogenic effects of chromium-containing compounds on mammalian cells in culture. Mutation Res. 67:1979;55-63.
50. Sugiyama M., Wang X.W., Costa M. Comparison of DNA lesions and cytotoxicity induced by calcium chromate in human, mouse and hamster cell lines. Cancer Res. 46:1986;4547-4551.
51. MacRae W.D., Whiting R.F., Stich H.F. Sister-chromatid exchanges induced in cultured mammalian cells by chromate. Chem. Biol. Interact. 26:1979;281-286.
52. Gao M., Binks S.P., Chipman J.K., Levy L.S. Hexavalent chromium produces DNA strand breakage but not unscheduled DNA synthesis at sub-cytotoxic concentrations in hepatocytes. Toxicology. 77:1993;171-180.
53. Cupo D.Y., Wetterhahn K.E. Binding of chromium to chromatin and DNA from liver and kidney of rats treated with sodium dichromate and chromium (III) chloride in vivo. Cancer Res. 45:1985;1146-1151.
54. Fornace A.J. Jr. Detection of DNA single-stranded breaks produced during the repair of damage by DNA-protein cross-linking agents. Cancer Res. 42:1982;145-149.
55. Costa M. DNA-protein complexes induced by chromate and other carcinogens. Environ. Health Perspect. 92:1991;45-52.
56. De Flora S., Bagnasco M., Serra D., Zanacchi P. Genotoxicity of chromium compounds, a review. Mutation Res. 238:1990;99-172.
57. Aiyar J., Berkovits H.J., Floyd R.A., Wetterhahn K.E. Reaction of chromium (VI) with glutathione or with hydrogen peroxide: identification of reactive intermediates and their role in chromium (V)-induced DNA damage. Environ. Health Perspect. 92:1991;53-62.
58. Borges K.M., Boswell J.S., Liebross R.H., Wetterhahn K.E. Activation of chromium (VI) by thiols results in chromium (V) formation, chromium binding to DNA and altered DNA formation. Carcinogenesis. 12:1991;551-561.
59. Faux S.P., Gao M., Chipman J.K., Levy L.S. Production of 8-hydroxydeoxyguanosine in isolated DNA by chromium (VI) and chromium (V). Carcinogenesis. 13:1992;1667-1669.
60. Shi X.L., Dalal N.S. Evidence for a Fenton-type mechanism for the generation of ·OH radicals in the reduction of Cr(VI) in cellular media. Arch. Biochem. Biophys. 281:1990;90-95.
61. Lyer V.N., Szybalski W. Mitomycins and porfiromycin: chemical mechanism of activation and cross-linking of DNA. Science. 145:1964;55-58.
62. Wang Y.Y., Maher V.M., Liskay R.M., McCormick J.J. Carcinogens can induce homologous recombination between duplicated chromosomal sequences in mouse L cells. Mol. Cell. Biol. 8:1988;196-202.
63. Graf U., Heo O.S., Ramirez O.O. The genotoxicity of chromium(VI) oxide in the wing spot test of Drosophila melanogaster is over 90% due to mitotic recombination. Mutation Res. 266:1992;7-203.
64. Gladek A., Liehr J.G. Mechanism of genotoxicity of diethylstilbestrol in vivo. J. Biol. Chem. 264:1989;16847-16852.
65. Rudiger H.W., Haenish F., Metzler M., Oesch F., Glatt H.R. Metabolites of diethylstilbestrol induce sister chromatid exchange in human cultured fibroblasts. Nature. 281:1979;392-394.
66. Tsutsui T., Degen G.H., Schiffmann D., Wong A., Maizumi H., McLachlan J.A., Barrett J.C. Dependence on exogenous metabolic activation for induction of unscheduled DNA synthesis in Syrian hamster embryo cells by diethylstilbestrol and related compounds. Cancer Res. 44:1984;184-189.
67. Tsutsui T., Maizumi H., McLachlan J.A., Barrett J.C. Aneuploidy induction and cell transformation by diethylstilbestrol: a possible chromosomal mechanism in carcinogenesis. Cancer Res. 43:1983;3814-3821.
68. Korah R.M., Humayun M.Z. Mutagenic and recombinagenic effects of diethylstilbestrol quinone. Mutation Res. 289:1993;205-214.
69. Vogel E.W., Nivard M.J. Performance of 181 chemicals in a Drosophila assay predominantly monitoring interchromosomal mitotic recombination. Mutagenesis. 8:1993;57-81.
70. Crebelli R., Carere A. Chemical and physical agents assayed in tests for mitotic intergenic and intragenic recombination in Aspergillus nidulans diploid strains. Mutagenesis. 2:1987;469-475.
71. Gennart J.P., Baleux C., Verellen-Dumoulin C., Buchet J.P., De Meyer R., Lauwerys R. Increased sister chromatid exchanges and tumor markers in workers exposed to elemental chromium-, cobalt- and nickel-containing dusts. Mutation Res. 299:1993;55-61.
72. Nackerdien Z., Kasprzak K.S., Rao G., Halliwell B., Dizdaroglu M. Nickel(II)- and cobalt(II)-dependent damage by hydrogen peroxide to the DNA bases in isolated human chromatin. Cancer Res. 51:1991;5837-5842.
73. 32P-postlabeling. Mutation Res. 291:1993;147-159.
74. Tkeshelashvili L.K., Reid T.M., McBride T.J., Loeb L.A. Nickel induces a signature mutation for oxygen free radical damage. Cancer Res. 53:1993;4172-4174.
75. Jones J.A., Starkey J.R., Kleinhofs A. Toxicity and mutagenicity of sodium azide in mammalian cell cultures. Mutation Res. 77:1980;293-299.
76. Sander C., Nilan R.A., Kleinhofs A., Vig B.K. Mutagenic and chromosome-breaking effects of azide in barley and human leukocytes. Mutation Res. 50:1978;67-75.
77. Slameñová D., Gabelová A. The effects of sodium azide on mammalian cells cultivated in vitro. Mutation Res. 71:1980;253-261.
78. Owais W.M., Rosichan J.L., Ronald R.C., Kleinhofs A., Nilan R.A. A mutagenic metabolite synthesized by Salmonella typhimurium grown in the presence of azide is azidoalanine. Mutation Res. 118:1983;229-239.
79. Veleminsky J., Silhankova L., Smiovska V., Gichner T. Mutagenesis of Saccharomyces cerevisiae by sodium azide activated in barley. Mutation Res. 61:1979;197-205.
80. Allavena A., Martelli A., Robbiano L., Brambilla G. Evaluation in a battery of in vivo assays of four in vitro genotoxins proved to be noncarcinogens in rodents. Teratog. Carcinog. Mutag. 12:1992;31-41.
81. Cox R.P., Krauss M.R., Balis M.E., Dancis J. Evidence for transfer of enzyme product as the basis of metabolic cooperation between tissue culture fibroblasts of Lesch-Nyhan disease and normal cells. Proc. Natl. Acad. Sci. USA. 67:1970;1573-1579.
82. Cole J., Skopek T.R. International commission for protection against environmental mutagens and carcinogens, Working paper No.3. Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. Mutation Res. 304:1994;33-105.
83. Hahn P., Nevaldine B., Morgan W.F. X-ray induction of methotrexate resistance due to dhfr gene amplification. Somat. Cell Mol. Genet. 16:1990;413-423.
84. Brown P.C., Tlsty T.D., Schimke R.T. Enhancement of methotrexate resistance and dihydrofolate reductase gene amplification by treatment of mouse 3T6 cells with hydroxyurea. Mol. Cell. Biol. 3:1983;1097-1107.
85. Tlsty T.D., Brown P.C., Schimke R.T. UV radiation facilitates methotrexate resistance and amplification of the dihydrofolate reductase gene in cultured 3T6 mouse cells. Mol. Cell. Biol. 4:1984;1050-1056.
86. Schimke R.T. Gene amplification in cultured animal cells. Cell. 37:1984;705-713.
87. Goldberg I., Mekalanos J.J. Effect of a recA mutation on Cholera toxin gene amplification and deletion events. J. Bacteriol. 165:1986;723-731.
88. Flintoff W.F., Davidson S.V., Siminovitch L. Isolation and partial characterization of three methotrexate-resistant phenotypes from Chinese hamster ovary cells. Somat. Cell Genet. 2:1976;245-261.
89. Haber D.A., Beverley S.M., Kiely M.L., Schimke R.T. Properties of an altered dihydrofolate reductase encoded by amplified genes in cultured mouse fibroblasts. J. Biol. Chem. 256:1981;9501-9510.
90. Sharma R.C., Schimke R.T. Enhancement of the frequency of methotrexate resistance by gamma-radiation in Chinese hamster ovary and mouse 3T6 cells. Cancer Res. 49:1989;3861-3866.
91. Sirotnak F.M., Moccio D.M., Kelleher L.E., Goutas L.J. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo. Cancer Res. 41:1981;4447-4452.
92. Knaap A.G., Meera Khan P., Simons J.W. Establishment of a dose-response relationship for reverse mutation at the HPRT (hypoxanthine guanine phosphoribosyl transferase) locus in L5178Y mouse lymphoma cells. Mutation Res. 96:1982;259-271.